Nutritional Elements in Sleep

Pattnaik, Harsha; Mir, Mikael; Boike, Sydney; Kashyap, Rahul; Khan, Syed Anjum; Surani, Salim

doi:10.7759/cureus.32803

Cited by 5 publications

(4 citation statements)

References 115 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Self-management of sleep disruption should be encouraged by helping people with MS understand the circadian rhythm and how body temperature, light exposure and nutrition can impact sleep architecture (Figure 2). Tailoring sleep hygiene advice to the individual is important for those with MS, considering symptoms, medication and side effects, and ensuring information on physical activity, natural light and nutrition are personalised (43)(44)(45)(46).…”

Section: Sleep Disordersmentioning

confidence: 99%

MS care: integrating advanced therapies and holistic management

Giovannoni,

Ford,

Schmierer

et al. 2024

Front. Neurol.

View full text Add to dashboard Cite

Lifestyle and environmental factors are key determinants in disease causality and progression in neurological conditions, including multiple sclerosis (MS). Lack of exercise, poor diet, tobacco smoking, excessive alcohol intake, social determinants of health, concomitant medications, poor sleep and comorbidities can exacerbate MS pathological processes by impacting brain health and depleting neurological reserves, resulting in more rapid disease worsening. In addition to using disease-modifying therapies to alter the disease course, therapeutic strategies in MS should aim to preserve as much neurological reserve as possible by promoting the adoption of a “brain-healthy” and “metabolically-healthy” lifestyle. Here, we recommend self-regulated lifestyle modifications that have the potential to improve brain health, directly impact on disease progression and improve outcomes in people with MS. We emphasise the importance of self-management and adopting a multidisciplinary, collaborative and person-centred approach to care that encompasses the healthcare team, family members and community support groups.

show abstract

Section: Sleep Disordersmentioning

confidence: 99%

MS care: integrating advanced therapies and holistic management

Giovannoni,

Ford,

Schmierer

et al. 2024

Front. Neurol.

View full text Add to dashboard Cite

show abstract

“…The 2022 surge remains unexplained, but declines in smallpox vaccination may enable orthopoxvirus re-emergence alongside new viral mutations, climate factors, population mobility, and waning herd immunity against mpox. [42] Active sexually transmitted diseases like syphilis or HIV may worsen mpox severity as cofactors. [43] Over 40% of analyzed mpox patients had HIV co-infection, with advanced/uncontrolled AIDS strongly predictive of poor prognosis.…”

Section: Epidemiology Of Mpoxmentioning

confidence: 99%

“…Over a period of 2–4 weeks, macules develop into papules, vesicles, pustules, and then crust over. [42] However, the entire cycle can be seen concurrently across lesions. Individual lesions enlarge to around 0.5–1 cm in size.…”

Section: Mpox Disease Course and Symptomsmentioning

confidence: 99%

Monkeypox: A Viral Zoonotic Disease of Rising Global Concern

Anil,

Joseph,

Thomas

et al. 2024

Infect Dis Immun

View full text Add to dashboard Cite

Monkeypox (mpox) is a rare viral zoonotic disease, endemic to Central and West Africa, caused by the monkeypox virus, an orthopoxvirus similar to the variola virus (smallpox). Although sporadic travel-associated cases have historically occurred outside Africa, in May 2022, mpox began spreading globally in multiple nonendemic countries across several continents. In 2024, there has been an increase in globally reported confirmed cases of mpox and deaths from mpox, making it a public health emergency of international concern. The reasons for the unusual global spread are under investigation but likely relate to increased travel and waning population immunity to orthopoxviruses. Transmission now appears to be mainly through close, intimate contact, especially among men who have sex with men. Mpox is usually a self-limited disease. Although limited approved antiviral treatments are available, such as tecovirimat, which the European Medicines Agency approved in January 2022 for the treatment of mpox, their widespread availability and effectiveness in the current outbreak remain to be investigated. Public health control measures include surveillance, case identification/isolation, contact tracing, and targeted vaccination of contacts at high risk of exposure. However, challenges remain in curtailing the current unprecedented outbreak. Critical knowledge gaps include animal reservoir(s) responsible for initial spillover events, viral mutations that may enhance transmissibility, optimal diagnostics for noninvasive specimens, effective antiviral therapies, next-generation vaccines providing longer-term immunity, and building global capacity for outbreak response. This review summarizes the current literature on mpox virology, epidemiology, pathogenesis, clinical manifestations, diagnostics, treatment, prevention, and public health control measures. Ongoing investigation and research are needed to better understand mpox’s evolving epidemiology, pathogenicity, transmissibility, and ecology to guide strategies for containing the outbreak and preventing future global emergence.

show abstract

“…In addition, specific causes of sleep disturbance (insomnia, obstructive sleep apnea) and more detailed information on the use of sleep medications were not evaluated. Given that diet [82,83] and caffeine consumption [84][85][86] can influence sleep quality and energy levels, these variables warrant evaluation in future studies. Because sleep disturbance was assessed using only a subjective measure, future studies need to examine the relationship between objective measures of sleep disturbance and decrements in morning energy.…”

Section: Limitationsmentioning

confidence: 99%